Steven Anderson, MD
Orthopaedic Surgery · North Wilkesboro, NCNPI 1295853018
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $34,716 of the $36,973 with a category attached, or 93.9%. Integrity Implants Inc. accounts for 93.9% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2019 at $35,079 and has fallen 99.7% since, to $100 in 2025.
Across 47 payments — averaging $786.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Integrity Implants Inc.$35K
- Smith+Nephew$1K
- Johnson & Johnson$201
- Medacta USA, Inc.$183
- Peerless Surgical Inc.$112
- Medical Device Business Services, Inc.$78
- plus $604 from 17 others
What the payments were for
- Royalty or licence$34,71694%
- Consulting fees$7882%
- Travel & lodging$420%
- Food & beverage$1,4274%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Integrity Implants Inc. | 4 | $34,716 |
| Smith+Nephew | 8 | $1,078 |
| Johnson & Johnson | 3 | $201 |
| Medacta USA, Inc. | 3 | $183 |
| Peerless Surgical Inc. | 1 | $112 |
| Medical Device Business Services, Inc. | 3 | $78 |
| Vericel Corporation | 1 | $74 |
| Stryker | 2 | $71 |
| Piedmont Plus Innovation | 1 | $62 |
| Pacira Pharmaceuticals Incorporated | 2 | $58 |
| Ferring Pharmaceuticals Inc. | 3 | $50 |
| Novo Nordisk | 2 | $35 |
| Zimmer Biomet | 2 | $34 |
| Amgen(2 entities) | 2 | $32 |
| Vertex | 1 | $30 |
| Medtronic | 1 | $25 |
| Pacira Therapeutics, Inc. | 1 | $22 |
| Radius Health, Inc. | 1 | $21 |
| Ipsen Biopharmaceuticals, Inc | 1 | $20 |
| Kinex Medical Company LLC | 2 | $20 |
| Bioventus LLC | 1 | $20 |
| Molnlycke Health Care US, LLC | 1 | $19 |
| Pfizer | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FlareHawk$34,716
- Journey II$438
- Journey II BCS$438
- Journey II CR$438
- LEGION TKS$438
- VISIONAIRE FastPak$438
How this compares
$36,973 in reported general payments places this provider in the 80th percentile of 845 orthopaedic surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 21 | $27 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in North Wilkesboro
- Thomas FehringCharlotte$18.3M
- Walter BeaverCharlotte$7.4M
- Robert AndersonCharlotte$6.6M
- William JiranekDurham$6.4M
- John MasonCharlotte$5.7M
- Thomas VailDurham$5.7M
- William DavisCharlotte$5.2M
- John EllingtonCharlotte$4.9M
- Mark EasleyDurham$4M
- Carroll JonesCharlotte$3.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.